急性心肌梗死患者血浆N末端B型利钠肽原水平与经皮冠状动脉介入术中无复流的关系
摘要
急诊经皮冠状动脉介入治疗(PCI)术中无复流是影响治疗效果和临床预后的重要因素,目前虽有许多治疗措施,但效果均不尽如人意,因此对于PCI术中的无复流应该重存预防。近年研究发现,发生急性心肌梗死时,各种神经和内分泌系统(如凝血系统、心脏利钠肽系统)及炎性反应等被激活,并与心肌梗死的预后相关。
出处
《上海医学》
CAS
CSCD
北大核心
2011年第11期884-885,共2页
Shanghai Medical Journal
参考文献6
-
1HAMMOUDEH A J, ALHADDAD I A. Triggers and the onset of acute myocardial infarction[J]. Cardiol Rev, 2009, 17(6) : 270-274.
-
2NDREPEPA G, TIROCH K, FUSARO M, et al. 5-year prognostic value of no-reflow phenomenon after percutaneouscoronary intervention in patients with acute myocardial infarction[J]. J Am Coil Cardiol, 2010, 55(21)- 2383-2389.
-
3EITEL. I, NOWAK M, STEHL C, et al. Endothelin-1 release in acute myocardial infarction as a predictor of long- term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging[J]. Am Heart J, 2010, 159(5) : 882-890.
-
4施佳,金惠根,欧少君,刘宗军,汪蔚青,杨伟,王东毅,汪志华,沈峻,于宏梅.预测急性心肌梗死急诊介入治疗无复流的临床和冠状动脉造影特征[J].上海医学,2010,33(5):430-433. 被引量:10
-
5颜红兵,朱小玲,高海,李南,李世英,艾辉,王健,柯元南.直接冠状动脉介入治疗时无复流高危患者是否应用Guardwire Plus装置的对比研究[J].中国介入心脏病学杂志,2005,13(3):138-141. 被引量:11
-
6JEONG Y H, KIM W J, PARK D W, et al. Serum B-type natriuretic peptide on admission can predict the'no-reflow" phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction[J]. Int J Cardiol, 2010, 141(2):175-181.
二级参考文献25
-
1颜红兵,高焱莎,万鹏,刘景山,柯元南.急诊经桡动脉应用Percusurge Guardwire装置一例[J].中国介入心脏病学杂志,2004,12(6):351-351. 被引量:1
-
2Kelly R V,Cohen M G,Stouffer G A.Incidence and management of "no-reflow" following percutaneous coronary interventions.Am J Med Sci,2005,329:78-85.
-
3Ito H.No-reflow phenomenon and prognosis in patients with acute myocardial infarction.Nat Clin Pract Cardiovasc Med,2006,3:499-506.
-
4Simes R J,Topol E J,Holmes D R Jr,et al.Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion.Importance of early and complete infarct artery reperfusion.GUSTO-I Investigators.Circulation,1995,91:1923-1928.
-
5Kubica J,Koziiski M.No-reflow phenomenon:Achilles' heel of primary coronary angioplasty in acute myocardial infarction.Cardiol J,2008,15:1-3.
-
6Olszowska M,Tracz W,Kostkiewicz M,et al.Predictive factors of myocardial reperfusion in patients with anterior wall acute myocardial infarction.Cardiol J,2008,15:57-62.
-
7De Luca G,Ernst N,Zijlstra F,et al.Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty.J Am Coll Cardiol,2004,43:1363-1367.
-
8Kloner R A,Rude R E,Carlson N,et al.Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion:which comes first?Circulation,1980,62:945-952.
-
9Hearse DJ,Bolli R.Reperfusion induced injury:manifestations,mechanisms,and clinical relevance.Cardiovasc Res,1992,26:101-108.
-
10Yoshiki N,Kazuo U,Akio U,et al.Pathological analysis of intracoronary thrombus (thrombectomy catheter samples) in acute myocardial infarction.Respiration and Circulation,2002,50:315-320.
共引文献19
-
1黄定,马翔,马依彤.抽吸导管在急性心肌梗死介入治疗中的应用体会[J].中华临床医师杂志(电子版),2012,6(21):6937-6939. 被引量:1
-
2张国明,王禹,陈练,盖鲁粤,杨庭树,孙志军,金琴花,王峙峰,计达.急性冠状动脉综合征患者急诊介入治疗临床研究[J].中华老年心脑血管病杂志,2007,9(3):159-162. 被引量:5
-
3YAN Hong-bing WANG Jian LI Nan ZHU Xiao-ling GAO Hai AI Hui LI Xiang YE Ming CHI Yun-peng ZHANG Hong.Diver CE versus Guardwire Plus for thrombectomy in patients with inferior myocardial infarction:a trial of aspiration of thrombus during primary angioplasty for inferior myocardial infarction[J].Chinese Medical Journal,2007(7):557-561. 被引量:29
-
4李南,颜红兵,朱小玲,高海,艾辉,王健,李响,叶明,迟云鹏,张宏.急性下壁心肌梗死应用Guardwire Plus与Diver CE两种装置的对比研究[J].中华心血管病杂志,2007,35(5):461-465. 被引量:3
-
5颜红兵,朱小玲,艾辉,李南,高海,王健,李响,叶明,迟云鹏,张晓江.急性前壁心肌梗死应用DiverCE抽吸导管的有效性:TAPAFAMI试验[J].中国介入心脏病学杂志,2007,15(3):145-148. 被引量:13
-
6曹艳杰,李成祥,王海昌,袁铭,冯旭阳,范延红,胡涛.远端血管保护装置在急性ST段抬高心梗中的应用[J].解放军医学杂志,2008,33(10):1253-1255.
-
7曾宪辉,蔚青,周苏宁.冠脉再通术后心肌微循环障碍的中医药研究进展[J].辽宁中医杂志,2009,36(2):309-311. 被引量:1
-
8赵汉军,颜红兵,李狄,刘臣,李文铮,马芹,王伟,王健,李庆祥,李世英,迟云鹏,吴铮,陈东.急性心肌梗死冠状动脉内抽吸物的病理分析[J].中华心血管病杂志,2009,37(9):785-789. 被引量:27
-
9潘朝锌,何贵新.经皮冠状动脉介入治疗术后无复流现象的研究进展[J].微创医学,2010,5(5):506-509. 被引量:4
-
10胡立群,顾晔,曾昆,高波.急诊经皮冠状动脉球囊扩张成形术延期支架植入对急性ST段抬高心肌梗死患者预后的影响[J].上海医学,2011,34(1):54-57. 被引量:3
-
1陈林琴,陶晓军.C-反应蛋白与降钙素原联合检测对肺部感染病原体的鉴别[J].中国实用乡村医生杂志,2015,0(19):39-40.
-
2胡中泉,何同林,湛雪群,刘俊华.NT-proBNP在评估血液透析患者干体质量中的临床价值[J].深圳中西医结合杂志,2016,26(11):92-94. 被引量:1
-
3胡善友,康文惠,王飞,任广胜,林兆奋.联合检测cTnT和NT-proBNP在危重病患者预后中的应用价值[J].成都医学院学报,2013,8(6):683-686.
-
4周炳烨.实验室检测N末端B型利钠肽原的影响因素分析[J].山西医药杂志,2014,43(14):1725-1727.
-
5刘艳.冠心病合并糖尿病患者的NT-proBNP水平与肾功能和血脂水平的关系[J].国际检验医学杂志,2012,33(17):2144-2145. 被引量:12
-
6舒兴业.冻干重组人脑利钠肽治疗急诊急性心力衰竭的效果观察[J].中国社区医师,2017,33(6):17-17. 被引量:4
-
7陆莹,韩薇,杜玉凤,狄伟南.维持性血液透析患者透析中低血压的发生情况及原因分析[J].中国血液流变学杂志,2014,0(4):513-515. 被引量:4
-
8于广周.脑梗死患者超敏C反应蛋白、纤维蛋白原的检测及其临床意义[J].中国现代药物应用,2016,10(20):41-42. 被引量:2
-
9王长远,秦俭.N末端B型利钠肽原在急诊老年呼吸困难患者鉴别中的应用意义[J].临床肺科杂志,2012,17(11):1977-1978. 被引量:5
-
10王培蕊.脑梗死急性期血浆纤维蛋白原水平与预后[J].中国实用医药,2017,12(3):79-80. 被引量:3